Skip to content

Effects of Enriched Gardens in Nursing Home Residents With Dementia

Effects of Enriched Gardens on Cognition and Independence of Nursing Home Residents With Dementia: a Cluster-controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04903171
Enrollment
130
Registered
2021-05-26
Start date
2020-03-15
Completion date
2020-10-15
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Alzheimer, Enriched garden, Enriched environment, Dementia, Cognitive impairment, Functional autonomy

Brief summary

Comparing the effect of the frequentation of an enriched garden vs sensory conventional garden by nursing home residents with Alzheimer disease. The effects will be evaluated as regards to cognitive impairment (MMSE), autonomy (ADL) and prevention of falls (Unipodal stance and UpandGo Test)

Detailed description

The cluster controlled trial is conducted over a six months period after recruitment of residents from 4 different nursing homes in France. The participants are distributed into 3 groups. One group does not receive incentive from carers to visit any garden, the second group receives incentives to visit regularly a conventional sensory garden and the third group receive incentives from carers to visit regularly an enriched garden. The study is conducted over a period of 6 months. All participants are giving consent to the study. They will be evaluated before and after over 4 different tests. MMSE (Mini Mental Status Examination) for cognitive impairment, ADL (Activity for day Living) for functional autonomy, TUG (Test up and Go) and Unipodal Stance for prevention of falls.

Interventions

OTHERINCENTIVE VISITING A GARDEN : ENRICHED OR CONVENTIONAL SENSORY GARDEN

Carers invites every the participants of group 2 and 3 visiting their respective gardens (enriched or conventional sensory garden)

Sponsors

RIVAGES
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The investigators and outcomes assessor do not know which groups the participants belongs to

Intervention model description

Cluster controlled trial

Eligibility

Sex/Gender
ALL
Age
75 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* Give consent * Ability walking alone * Alzheimer's disease

Exclusion criteria

* No dementia * Severe dementia * Severe behavioural disorder * Inability to walk alone

Design outcomes

Primary

MeasureTime frameDescription
Change in global cognitive function6 MONTHSMini Mental Status Examination (MMSE) , 0-30, higher score is the better outcome
Change in functional independence6 MONTHSActivities of daily living (ADL), 0-6, higher score is the better outcome

Secondary

MeasureTime frameDescription
Change in gait ability6 MONTHSTimed Up and Go test (sec), higher time is the worse outcome
Change in balance6 MONTHSUnipodal Stance (sec), higher time is the better outcome

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026